Bicara Therapeutics Inc
(BCAX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCAX | AZN | AMGN | GILD | VRTX |
| Company | Bicara Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 14.22 | 205.64 | 362.65 | 151.89 | 471.64 |
| High | 14.78 | 206.71 | 370.42 | 156.95 | 503.88 |
| Low | 14.03 | 204.09 | 361.71 | 151.46 | 471.64 |
| Latest | 14.21 | 205.55 | 369.19 | 154.98 | 491.47 |
| Change | +0.15 | +1.03 | +2.99 | +3.17 | +26.45 |
| % Change | +1.07% | +0.50% | +0.82% | +2.09% | +5.69% |
| Volume | 250,300 | 2,504,800 | 2,414,100 | 6,861,900 | 2,918,300 |
| 20-Day Average Volume | 374,095 | 4,517,215 | 3,213,090 | 8,929,340 | 1,653,240 |
| Previous Close | 14.06 | 204.52 | 366.20 | 151.81 | 465.02 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.09 | 189.62 | 353.45 | 142.05 | 467.59 |
| 20-Day Raw Stochastic | 9.23% | 95.95% | 74.88% | 93.44% | 83.43% |
| 20-Day Relative Strength | 37.24 | 65.52 | 61.52 | 69.29 | 60.74 |
| Weighted Alpha | +3.49 | +49.13 | +33.73 | +59.72 | +13.91 |
| Today's Opinion | 8% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 8% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 64% Buy | 72% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.49% since 02/06/26 | +6.49% since 02/06/26 | -3.94% since 02/06/26 | +1.63% since 02/06/26 | +2.84% since 02/06/26 |
| Low | 13.80 on 02/12/26 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 147.07 on 02/10/26 | 454.40 on 02/11/26 |
| High | 15.50 on 02/11/26 | 206.71 on 02/13/26 | 384.62 on 02/09/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 1-Month | |||||
| %Chg | -18.94% since 01/13/26 | +8.75% since 01/13/26 | +13.84% since 01/13/26 | +27.28% since 01/13/26 | +8.09% since 01/13/26 |
| Low | 13.80 on 02/12/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 120.94 on 01/15/26 | 429.00 on 01/20/26 |
| High | 18.24 on 01/22/26 | 206.71 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 3-Month | |||||
| %Chg | -0.35% since 11/13/25 | +15.99% since 11/13/25 | +9.88% since 11/13/25 | +23.79% since 11/13/25 | +13.11% since 11/13/25 |
| Low | 13.80 on 02/12/26 | 176.56 on 11/14/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 418.53 on 11/19/25 |
| High | 19.68 on 12/11/25 | 206.71 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 6-Month | |||||
| %Chg | +25.42% since 08/13/25 | +31.86% since 08/13/25 | +27.60% since 08/13/25 | +29.00% since 08/13/25 | +24.13% since 08/13/25 |
| Low | 10.30 on 09/22/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 19.71 on 10/13/25 | 206.71 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 778,452 | 318,789,152 | 198,801,792 | 192,280,576 | 124,695,272 |
| Shares Outstanding, K | 54,782 | 1,550,908 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -68,000,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -36,330,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | -0.79 | 0.34 | 0.46 | 0.36 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.67 on 11/10/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 03/26/26 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.25 | 16.76 | 18.63 | 28.32 |